glp 1 mw Frontiers GLP-1 receptor agonists and next-generation

These agents may provide additional therapeutic benefits beyond glycemic control

GxE interactions for the mitochondrial folate carrier SLC25A32 The fitness defects of SLC25A32 KOs observed in glucose, antimycin and pyruvate conditions are buffered in galactose in the screen (Fig

Are there any side effects to glutathione

Behavioral testing was followed by biochemical analyses on colon, faces, serum, cerebellum, and prefrontal cortex, assessing tryptophan metabolites, serotonin (5-HT) pathway intermediates, neurotransmitters (GABA, glutamate, dopamine, acetylcholine) via UPLC, UPLC-TQD, and ELISA, alongside gut microbiota profiling through 16S r RNA sequencing